Abstract--Novel 2-deoxo-2-phenyl-5-deazaflavins and 2-deoxo-2-phenylflavin-5-oxides were prepared as a new class of antitumor agents and showed significant antitumor activities against NCI-H 460, HCT 116, A 431, CCRF-HSB-2, and KB cell lines. In vivo investigation, 2-deoxo-10-methyl-2-phenyl-5-deazaflavin exhibited the effective antitumor activity against A 431 human adenocarcinoma cells transplanted subcutaneously into nude mouse. Furthermore, AutoDock study has been done by binding of the flavin analogs into PTK pp60 c-src , where a good correlation between their IC 50 and AutoDock binding free energy was exhibited. In particular, 2-deoxo-2-phenylflavin-5-oxides exhibited the highest potential binding affinity within the binding pocket of PTK.
Introduction
During the last three decades there has been considerable interest in synthesis, functional elucidation, and biological evaluation of 5-deazaflavins {5-deazaisoalloxazines, pyrimido [4,5-b] quinoline-2,4(3H,10H)-diones}.
Actually, 5-deazaflavins have attracted great interest because of the first synthesis as potential flavin antagonists of flavin models 1 and of the discovery that they serve as co-factors for several flavin catalyzed reactions 2 (Scheme investigation of SAR between new inhibitors and protein tyrosine kinase (PTK). Thereupon, 2-deoxo-2-phenylflavin-5-oxide derivatives were designed and synthesized for the aim to get stronger binding affinity and more hydrogen bonds to the binding pocket of the PTK due to the polar part of the N-oxide moiety. In the present paper, we describe the preparation of 2-deoxo-2-phenyl-5-deazaflavins and 2-deoxo-2-phenylflavin-5-oxides and their antitumor activities, and also the AutoDock study for new inhibitors docked into the binding pocket of PTK. In this study, compounds having potential antitumor and PTK inhibitory activities, i.e., IC 50 values less than 25 µM, were docked into the binding pocket of PTK using AutoDock 3.05
program.
Results and Discussion

Chemistry
The required 6-N-monoalkylanilino-2-phenylpyrimidin-4(3H)-ones (1a-j), which were used as precursors for synthesis of 2-deoxo-2-phenyl-5-deazaflavins (2a-g) and 2-deoxo-2-phenylflavin-5-oxide (3a-i), were synthesized by fusion of 6-chloro-2-phenylpyrimidin-4(3H)-one with appropriate N-alkyl anilines at 180-200 °C under nitrogen atmosphere for 0.5-5 hours according to the known procedure 13 as shown in Scheme 2. The commercially unavailable N-monomethylated anilines were synthesized from appropriate aniline derivatives in 2-steps, by reaction of anilines with ethyl formate under reflux for 15 hours to get the N-arylformamides and followed by reduction using LiAlH 4 in THF to afford the corresponding N-monomethylated anilines. 14 The intended 10-alkylated 2-deoxo-2-phenyl-5-deazaflavins (2a-g) were prepared by reaction of 1a, b, d-h with Vilsmeier reagent (N,N-dimethylformamide-phosphoryl chloride) at 90 °C for 1-4 hours, and the 10-unsubstituted derivatives (2h-j) were prepared from 6-anilino-2-phenylpyrimidin-4(3H)-ones 15 in the same conditions of Vilsmeier reaction. This synthetic method is an useful preparation for 5-deazaflavins from 6-(N-monoalkylanilino) uracils. 16 The 10-methyl-2-phenylpyrimido [4,5-b] quinolin-4(10H)-one (2a) was also prepared by methylation of 2-phenylpyrimido [4,5-b] quinolin-4(10H)-one (2h) with excess methyl iodide in the presence of anhydrous potassium carbonate in DMF at room temperature in 80% yield. On the other hand, 2-deoxo-2-phenylflavin-5-oxide (3a-i) were prepared by nitrosative cyclization of 6-N-monoalkylanilino-2-phenylpyrimidin-4(3H)-ones (1a-h, j) with excess NaNO 2 in AcOH at 10-15 °C for 2-5 hours. However, such cyclization of 1i was difficult due to the peri steric hindrance between the ethyl at the N-ethyl and the ortho methyl of aniline moiety.
The structures of the products 1a-j were confirmed in particular by the presence of an equivalent proton resonance at the 5-position as a singlet signal at δ H 4.8-5.3 in 1 H NMR spectra and by the presence of the C 5 carbon signal at δ C 86-87 in 13 C NMR spectra ( Table 1 ). The cyclized 2-deoxo-2-phenyl-5-deazaflavins (2a-j) showed a characteristic singlet signal in the lower field at δ H 9.2-9.4 due to the proton at the 5-position of 2a-j and a signal at δ C 137-141 due to the carbon at the 5-position. It is implying that the 5-position of 2a-j is the most electron-deficient methine and very reactive to nucleophiles. Whereas, the 2-deoxo-2-phenylflavin-5-oxides (3a-i)
showed no such signals at the 5-position. On the other hand, the UV absorption spectra of the anilinopyrimidones (1a-j) showed one absorption maximum at 253-257 nm together with an absorption maximum as shoulder at 272-274 nm. Whereas, the 10-alkylated deazaflavins (2a-g) showed four absorption maxima at 283-297, 336-355, 414-431 and 433-456 nm together with an absorption maximum as shoulder at 262-288 nm, and the 10-unsubstituted deazaflavins (2h-i) also showed three absorption maxima at 279-290, 364-370, and 374-385 nm, which were observed with hypsochromic shift in the region of the longest wavelength in comparison with those of 2a-g,, together with an absorption maximum as shoulder at 254-256 nm. In contrast with the above UV absorption spectra, the 2-deoxo-2-phenylflavin-5-oxides (3a-i) exhibited the absorptions in the region of longer wavelength,
i.e., four absorption maxima at 303-312, 362-373, 470-496 and 500-528 nm together with an absorption maximum as shoulder at 292-302 nm. All compounds of 3a-i showed red color owing to the presence of absorption maximum at ca. 515 nm in the longest wavelength.
Scheme 2.
General method for the preparation of 6-(N-alkylanilino)-2-phenylpyrimidin-4(3H)-ones(1a-j), 2-deoxo-2-phenyl-5-deazaflavins (2a-j), and 2-deoxo-2-phenylflavin-5-oxides (3a-i).
In vitro antitumor activities of deazaflavin and flavin analogs against human tumor cell lines
The synthesized compounds 2a-j and 3a-i were tested in vitro for growth inhibitory activities against various cultured tumor cell lines. Five human tumor cell lines including human lung cancer cell line (NCI-H 460), human colon carcinoma cell line (HCT 116), human adenocarcinoma cell line (A 431), human T-cell acute lymphoblastoid leukemia cell line (CCRF-HSB-2) and human oral epidermoid carcinoma cell line (KB) were used, and the antitumor agents of Ara-C, cisplatin and adriamycin were also used as positive controls in this study.
As can be seen from Table 2 , many compounds of flavin analogs such as 2-deoxo-2-phenyl-5-deazaflavins (2) and 2-deoxo-2-phenylflavin-5-oxides (3) have been found to show fairly good antitumor activities. Although the tested flavin analogs showed a little poor antitumor activities than that of cisplatin against NCI-H 460 cell line, their activities for the compounds 2a, 2c, 3a, and 3f against HCT 116 cell line were higher than cisplatin.
Especially, compound 3f (IC 50 : 0.72 µM ) exhibited 3 folds more potent antitumor activity than that of cisplatin (IC 50 : 2.23 µM). Further, against A 431 cell line they showed less antitumor activities in comparison with adriamycin. Though it is also inferior to the antitumor activity of Ara-C (IC 50 : 0.15 µM), many compounds showed 0.5-2.0 µM potential growth inhibitory activities against CCRF-HSB-2 cell line. In case against KB cell line, many compounds showed 0.5-5.0 µM potential growth inhibitory activities and the compounds 2e and 2g (IC 50 : 0.5 µM) exhibited more potent antitumor activities than that of Ara-C (IC 50 : 0.70 µM).
In vivo antitumor activity against subcutaneously transplanted human adenocarcinoma A 431 xenograft
In vivo research has an advantage to discover drugs as the nature and properties of a chemical tool cannot be considered independently. Therefore, the antitumor activities of compounds 2a and 2b against subcutaneously transplanted human adenocarcinoma A 431 xenograft in mice were measured, and the tumor volume and body weights of mice were evaluated. Thus the human adenocarcinoma A 431 was subcutaneously transplanted into BALB/c nude mice, and the administration of test compounds was started on the day (day 1) when the mice show tumor growth in the 100-300 mm 3 range. Since the test compounds prepared here showed poor solubility in water, the administrations were done by intratumoral (i.t.), intraperitoneal (i.p.) or oral (p.o.) methods. Table 3 Accordingly, the antitumor activity of compound 2a in vivo was shown to be more effective than compound 2b though compound 2a exhibited weaker activity than that of compound 2b against A431 tumor cells in vitro as shown in Table 2 . There is no fixed rule that the compound, which has biological activity in vitro, must exhibit the same effect in vivo. For example, the nonselective protein kinase inhibitor, staurosporine, did not exhibit any antitumor activity in vivo though it has much greater antiproliferative activity than UCN-01 A 431 cells were implanted subcutaneously into nude mice and the administration was started on the day when the mice show tumor growth in the 100-300 mm 3 range. 
Molecular docking study
The computer simulated automated docking studies were performed using the widely distributed molecular docking software, AutoDock 3.05.
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The AutoDock study of 2-deoxo-2-phenyl-5-deazaflavins (2a-j), 2-deoxo-2-phenylflavin-5-oxides (3a-i), and the computationally designed 3j and 2-deoxo-2-phenylflavins (4a-j) was carried out, and they were docked within the protein tyrosine kinase (PTK pp60 c-src , PDB code: 1skj). As shown in Table 4 and 4b didn't exhibit any hydrogen bond. As cited in literature, 19 the compound with the higher number of hydrogen bonds, with the lowest binding energy, and with the smallest RMSD (root mean square deviation) is generally said to be a reasonable candidate for potent inhibitors against the enzyme. Actually the docking results
showed that there was no significant difference between flavins and 2-deoxo-5-deazaflavins with respect to docking affinities into the binding site as shown in Table 4 and Figure 5 . This may be explained as CH and N are equivalent bioisosteres with similar size and comparable electronic properties. 
Mode of interaction of inhibitors within the binding pocket
Most docked inhibitors interacted by the same mode of the co-crystallized ur2 ligand within the PTK binding site. 
Conclusion
In this study, ten 2-deoxo-5-deazaflavins (2a-j) and nine flavin-5-oxides (3a-i) were synthesized to investigate their biological activities. In vitro growth inhibitory activities of compounds 2a-j and 3a-i against NCI-H 460, HCT 116, A 431, CCRF-HSB-2 and KB cells showed significant potential antitumor activities. Interestingly, the activities of some compounds 2a, 2c, 3a and 3f against HCT 116 cells were higher than that of cisplatin. The AutoDock study of 2-deoxo-2-phenyl-5-deazaflavins (2a-j), 2-deoxo-2-phenylflavin-5-oxides (3a-j), and 2-deoxo-2-phenylflavins (4a-j) was carried out, and they were docked within the protein tyrosine kinase (PTK 
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General procedure for the preparation of 2-deoxo-2-phenyl-5-deazaflavin derivatives (2a-j).
A mixture of 6-(N-alkylanilino)-or 6-anilino-2-phenylpyrimidin-4(3H)-ones 15 (1, 0.05 mol) and phosphoryl chloride (77 g, 0.5 mol) in N,N-dimethylformamide (100 mL) was heated under stirring at 90 °C for 1-4 h. Then, the reaction mixture was poured onto ice and neutralized with aqueous ammonia (pH 7). The yellow crystals, which separated, were filtered off, washed with water, dried and recrystallized from an appropriate solvent. All compounds were obtained as yellow (2a-g) or pale yellow needles (2h-j). , which was identical to the product (2a) prepared by the reaction of 1a with Vilsmeier reagent in all spectral data as described above.
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.d, J 7,9 = 2.1 Hz, 9-H), 7.55-7.72 (3 H, m, Ph-m,pH), 8.14 (1 H, d, J = 7.8 Hz, 6-H), 8.24-8.29 (1 H, m, Ph-oH)
General procedure for the preparation of 2-deoxo-2-phenylflavin-5-oxide derivatives (3a-i).
To a stirring solution of 6-(N-alkylanilino)-2-phenylpyrimidin-4(3H)-ones (1, 10 mmol) in acetic acid (5-15 mL) at 10-15 °C was added sodium nitrite (20-40 mmol) by portions, and the mixture was stirred for 2-5 h at room temperature. The solid deposited was collected by suction filtration and washed with water. Then, the solid dried was recrystallized from an appropriate solvent. All compounds were obtained as red needles. MTT-formazan that had formed. The optical density of each well was measured at 570 nm (OD 570 ) with a microplate reader and the inhibition of cell growth (%) was calculated as (1 -T/C) x 100, where C is the mean OD 570 of the control group and T is that of the treated group. The IC 50 was determined from the dose-response curve.
4,10-Dihydro-10-methyl-4-oxo-2-phenylbenzo[g]pteridine-5-oxide (3a
In vivo antitumor activities of 2-deoxo-2-phenyl-5-deazaflavins (2a and 2b)
Antitumor activity of 2-deoxo-2-phenyl-5-deazaflavins (2a, b) against subcutaneously transplanted human adenocarcinoma A 431 was tested according to the modified method developed by Inaba et al. 22 The Relative tumor volume (T/C %) was calculated by the Battele Columbus formula, T/C % = (Tn/T1) x 100/(Cn/C1), in which Cn = Tumor volume of control animals on day n, and Tn = Tumor volume of actively treated animals on day n of the treatment.
Docking study
AutoDock 3.05, 18 a grid-based docking program, was used for docking study. The crystal structure of protein tyrosine kinase pp60 c-src (PDB code: 1skj), 23 which is a c-src tyrosine kinase of Rous sarcoma virus, was used in this docking study. The 3D structure of 1skj was reported by Plummer et al. 23 
Docking parameters
Prior to the AutoDock, AutoGrid was carried out for the preparation of the grid map using a grid box with a npts (number of points in xyz) of 60-60-60 Å box and 120-120-120 Å box, which encloses the original ligand ur2.
The box spacing was 0.3 Å and grid center was designated at dimensions (x, y, z): -5.143, 62.487 and -8.776. A scoring grid was calculated from the original ligand structure (ur2) to minimize the computation time. Finally
AutoDock was run using maximum number of retries and generations of 10,000 and 27,000, respectively. The genetic algorithm with local search (GALS) was used for calculation of the docking possibilities. The complexes obtained by AutoDock were minimized using a maximum 300 iterations and the hybrid GALS runs with max of 250 cycles using different random number seeds to obtain score convergence.
Preparation of small molecules
ChemDraw ultra 8.0 software [Chemical Structure Drawing Standard; Cambridge Soft corporation, USA(2003)] was used for construction of compounds which were converted to 3D structures using Chem3D ultra 8.0 software and the constructed 3D structures were energetically minimized by using MOPAC (semi-empirical quantum mechanics) with AM1 mozyme geometry, 100 iterations and minimum RMS gradient of 0.10.
Evaluation of docked results
Accelrys DS modeling 1.5 software [DS modeling 1.5; Accelrys inc., San Diego, CA (2003)] was utilized for molecular modeling for the evaluation of hydrogen bonds in ligand-receptor interaction. The correct hydrogen bonds were considered if their geometry angle within 110-180 o acccording to Murray-Rust, et al. 24 While the false hydrogen bonds between N-oxide moiety and Cys42 were omitted because the bond angles were less than 90 o which are not matched with the considered parameters. Also DS modeling was used for measurement of RMSD, which was computed and expressed in Å as a structural comparison of two molecules in terms of distance. That is, it was measured as distance between the centroid of the docked inhibitor and the original ur2 ligand.
